SCHEMBL31293405

SCHEMBL31293405

O=C(O)C/C(=C/c1cccc(F)c1)C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RECQL P46063 1/20 0.50
▸ TSHR P16473 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ AKR1C3 P42330 1/20 0.47
▸ AKR1C2 P52895 1/20 0.46
▸ FBP1 P09467 1/20 0.45
▸ NFE2L2 Q16236 2/20 0.44
▸ MAPT P10636 1/20 0.44
▸ CYP3A4 P08684 2/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ PTGS1 P23219 2/20 0.42
▸ MMP1 P03956 1/20 0.42
▸ MMP2 P08253 1/20 0.42
▸ MMP9 P14780 1/20 0.42
▸ PPARG P37231 1/20 0.42
▸ MAOB P27338 1/20 0.42
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1655140 1.00 RECQL (0.50) RECQLTSHRCYP2C19AKR1C3AKR1C2
SCHEMBL1655139 1.00 RECQL (0.50) RECQLTSHRCYP2C19AKR1C3AKR1C2
SCHEMBL15890992 0.84 MAPT (0.53) AKR1C3AKR1C2FBP1NFE2L2MAPT
SCHEMBL15890993 0.84 MAPT (0.53) AKR1C3AKR1C2FBP1NFE2L2MAPT
SCHEMBL2224096 0.81 RECQL (0.72) RECQLTSHRCYP2C19AKR1C3MAPT
SCHEMBL166780 0.81 RECQL (0.72) RECQLTSHRCYP2C19AKR1C3MAPT
SCHEMBL5032754 0.81 RECQL (0.72) RECQLTSHRCYP2C19AKR1C3MAPT
SCHEMBL27158696 0.81 RECQL (0.72) RECQLTSHRCYP2C19AKR1C3MAPT
SCHEMBL1655835 0.81 RECQL (0.50) RECQLTSHRCYP2C19AKR1C3AKR1C2
SCHEMBL1655838 0.81 RECQL (0.50) RECQLTSHRCYP2C19AKR1C3AKR1C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4735449-A1 TETRACYCLIC COMPOUNDS CONTAINING A FUSED INDOLE FOR TREATING APOL1-MEDIATED CHRONIC KIDNEY DISEASE OmniAB, Inc. (US) 2026-05-06 — — EP disclosed
WO-2025006262-A1 TETRACYCLIC COMPOUNDS CONTAINING A FUSED INDOLE FOR TREATING APOL1-MEDIATED CHRONIC KIDNEY DISEASE OMNIAB, INC. (US) 2025-01-02 — — WO disclosed
Send feedback